Profitability
Weight: 15%
F
0
- 5yr Avg ROIC -24.5%
- Operating Margin Trend -21.87 pp/yr
RCUS
Arcus Biosciences, Inc.
AlphaQuality composite grade, weighted for high-growth software businesses.
⚠ 4 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a high-growth software business.
Grade overrides the 10.1 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
0
- 5yr Avg ROE -36.7%
- 5yr Share-Count CAGR 9.8%
Growth Quality
Weight: 35%
F
19
- 5yr Revenue CAGR -10.4%
- 5yr EPS CAGR 0.0%
- Revenue-Growth Years (5) 3/5
Cash Generation
Weight: 20%
F
0
- 5yr FCF Margin -46.8%
- 5yr FCF/NI Conversion -5.33x
Balance Sheet
Weight: 10%
F
2
- Net Debt / EBITDA 10.00x
- Interest Coverage (EBIT/Int) -43.12x
- Altman Z-Score 0.58
Stability
Weight: 5%
B-
63
- EPS Volatility (σ/μ) 0.00
- Piotroski F-Score 1
- Negative-Revenue Years (5) 2/5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.2 of 2 gurus held; 1 added; 1 trimmed.
- Holders
- 2
- Avg Δ position
- +53.5%
- New buys
- 0
- Full exits
- 0